EarningsNanalysis reported Q124 results that came in ahead of expectations, with a notable top-line beat driven by strong growth in both its Benchtop NMR and Security Services businesses.
Financial PerformanceThe company achieved adjusted EBITDA breakeven on the CATSA project as the majority of the significant one-time training costs were completed.
LiquidityNSCI closed its $5M public offering and concurrent private placement, bringing its total available liquidity to $6.7M, which is viewed as sufficient to bridge the company's path to profitability in 2025.